Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-08
2007-05-08
Kwon, Brian (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S168000, C514S561000
Reexamination Certificate
active
10294862
ABSTRACT:
A mixture obtained by mixing ascorbic acid powder with arginine powder in a weight ratio (ascorbic acid/arginine) of 1/5 to 20, especially 1/5 to 1/4; and a supplement such as a nutrient preparation and a health-care food containing the mixture. Mixing of arginine powder and ascorbic acid powder in the weight ratios eliminates stringent taste specific to arginine and alleviates stringent feeling in the stomach (heartburn, nausea or vomiting) after oral intake thereof. The mixture prevents also peroxidative injuries of cells caused by an administration of a great amount of arginine alone. Further, mixing of arginine powder with ascorbic acid powder prevents browning of the mixture after long-term storage.
REFERENCES:
patent: 4479974 (1984-10-01), Schenz
patent: 4871550 (1989-10-01), Millman
patent: 4913923 (1990-04-01), Van Den Ouweland
patent: 5719133 (1998-02-01), Schmidl et al.
patent: 5922766 (1999-07-01), Acosta et al.
patent: 6063432 (2000-05-01), Maxwell et al.
patent: 6344444 (2002-02-01), McCarty et al.
patent: 6359007 (2002-03-01), Pearson et al.
patent: 6368640 (2002-04-01), Wuh et al.
patent: 6514544 (2003-02-01), Fuchs et al.
patent: 6552074 (2003-04-01), Kimoto et al.
patent: 60066958 (1985-04-01), None
patent: 60078560 (1985-05-01), None
patent: 63115821 (1988-05-01), None
patent: 63115822 (1988-05-01), None
“L-Arginine and Ascorbic Acid for Diabetic Foot Ulcer”, Shellie Gorman, International Journal of Pharmaceutical Compounding, 2000, vol. 4, No. 2, pp. 94-96.
The Merck Index, Twelfth Edition, 1996, p. 867.
Bartsch et al., Pharmacogenetics, 2:272-7, 1994.
Liu et al., Carcinogenesis, abstract, 15:2875-7, 1992.
Ohshima et al., Mutations Research, 305:253-64, 1994.
Beckman et al., Proc. Natl. Acad. Sci, USA, 87, 1620-1624, 1990.
Cecil Textbook of Medicine, 20thEdition, vol. 1, 1996, pp. 1004-1010.
(“Systemic Lupus Erythematosus”, NewYork-Prebyterian Hospital, 2003.
Cardiovascular Diseases: Treatment of Stroke, Stanford Hospital and Clinics, 2005.
Genetic Disease Profile: Sickle Cell Anemia, Doegenomes.org, 2005.
Willard J. Visek, “Arginine Needs, Physiological State and Usual Diets. A Reevaluation”, Journal of Nutrition, vol. 116, pp. 36-46, 1986.
R. M. J. Palmer et al., “Nitric oxide release accounts for the bioloical activity of endothelium-derived relaxing factor”, Nature, vol. 327, pp. 524-526, 1987.
Marian Statter et al., “Competitive Interrelationships Between Lysine And Arginine In Rat Liver Under Normal Conditions And In Experimental Hyperammonemia”, Life Sciences, vol. 22, pp. 2097-2102, 1978.
D. Kritchevsky et al., “Atherogenicity of animal and vegetable protein. Influence of the lysine and arginine ratio”, Atheroscler., 41, 429-431, 1982.
Adrian Barbul, “Arginine: Biochemistry, Physiology, and Therapeutic Implications”, Journal of Parenteral and Enteral Nutrition, vol. 10, pp. 227-238, 1986.
R.C. Rose, “Ascorbic acid protection against free radicals”, Ann. N.Y. Acad. Sci., vol. 498, pp. 506-508, 1987.
B. Frei et al., “Ascorbate is an outstanding antioxidant in human blood plasma”, Proc. Natl. Acad. Sci. USA, vol. 86, pp. 6377-6381, 1989.
S. S. Mirvish, “Blocking the formation of N-nitroso compounds with ascorbic acid in vitro and in vivo”, Ann. N.Y. Acad. Sci., vol. 258, pp. 175-180, 1975.
W.H. Kalus et al., “Inhibition of nitrosamine formation of ascorbic acid: participation of free radicals in its anaerobic reaction with nitrite”, Experientia, vol. 36, pp. 147-149, 1980.
Joseph S. Beckman et al., “Pathological implications of nitric oxide, superoxide and peroxynitrite formation”, Biochem. Soc. Transact., vol. 21, pp. 330-334, 1993.
G.M. Sobala et al., “Ascorbic acid in the human stomach”, Gastroenterol., vol. 97, pp. 353-363, 1989.
Eli Seifter et al., “Arginine: An essential amino acid for injured rats”, Surgery, vol. 84, pp. 224-230, 1978.
E. Cameron et al., “Other Properties of Vitamin C”, Cancer and Vitamin C, pp. 112, 1979.
Kimoto Eiji
Morishige Fukumi
Kwon Brian
Oliff & Berridg,e PLC
LandOfFree
Arginine/ascorbic acid mixed powder as an oral supplement does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arginine/ascorbic acid mixed powder as an oral supplement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arginine/ascorbic acid mixed powder as an oral supplement will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3736740